Pharma news
Pharma
Endo and its subsidiary have challenged the FDA's approval of an application by BPI Labs and Belcher Pharmaceuticals | Dispute argues the FDA undermined regulatory frameworks and patent protection. 11 April 2024
Pharma
Diabetes drug is known for its off-label use as a weight-loss aid | Judge censures pharma giant for using state law instead of federal law in complaint | Development follows a wave of litigation involving Mounjaro. 11 April 2024
Biotech
Delaware district court more convinced by Arbutus on claim construction points | Canadian biotech “pleased” with outcome in latest round of dispute over lipid nanoparticles delivery system. 9 April 2024
Pharma
Annual global sales of Pfizer and Astella blockbuster drug reach roughly $5 billion |
Nonprofits argue the drug is sold at a price three to six times higher in the US than it’s priced in other similar high-income countries | Move to curb drug prices follows controversial march-in rights plan. 9 April 2024
Pharma
Senior pharma attorney and LSPN Boston speaker delves into emerging tech and patent law, the importance of communication and awareness, and the challenge of enablement | Advice on effective management of IP portfolios in the life sciences sector. 4 April 2024
Pharma
US Patent Trial and Appeal Board sides with the biotech pair in their challenge against Moderna's mRNA vaccine patents | Inter partes review challenges broad claims and monopolisation over mRNA tech. 21 March 2024
Pharma
Pharma giant says defendant initially concealed new role at competitor | Employee allegedly took “vast amounts” of confidential information and accessed it while employed by Pfizer. 21 March 2024
Pharma
ViQual Medical Technology had accused Kaiser Foundation Health Plan of stealing secrets related to monitors for diabetes and other conditions | California judge says no evidence confidential information was taken or used. 19 March 2024
Pharma
Amgen patents declared valid in Germany and Japan have also been deemed invalid by the European Patent Office, US Supreme Court, and in a separate Japan decision: but why? Takanori Abe of Abe & Partners examines the details. 19 March 2024
Pharma
Pharma company’s new partnership is an “opportunity” to accelerate access and maximise the potential of AstraZenica’s asthma drug | Delhi-based pharma firm will provide valuable distribution channels. 12 March 2024